Detalles de la búsqueda
1.
Prevalence and Natural History of Segmental Colitis Associated With Diverticulosis.
Am J Gastroenterol
; 118(11): 2088-2092, 2023 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37314163
2.
Prognostic performance of the 'DICA' endoscopic classification and the 'CODA' score in predicting clinical outcomes of diverticular disease: an international, multicentre, prospective cohort study.
Gut
; 71(7): 1350-1358, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34702716
3.
Vitamin D Signaling in Gastro-Rheumatology: From Immuno-Modulation to Potential Clinical Applications.
Int J Mol Sci
; 22(5)2021 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-33671090
4.
Development and validation of an endoscopic classification of diverticular disease of the colon: the DICA classification.
Dig Dis
; 33(1): 68-76, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25531499
5.
Exploring 6 years of colorectal cancer surgery in rural Italy: insights from 648 consecutive patients unveiling successes and challenges.
Updates Surg
; 76(3): 963-974, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38627306
6.
Ustekinumab safety and effectiveness in patients with ulcerative colitis: results from a large real-life study.
Expert Opin Biol Ther
; 24(1-2): 101-109, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38250818
7.
Diverticular Inflammation and Complication Assessment classification, CODA score and fecal calprotectin in clinical assessment of patients with diverticular disease: A decision curve analysis.
United European Gastroenterol J
; 11(7): 642-653, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37550901
8.
Comparison of Performances of Adalimumab Biosimilars SB5, ABP501, GP2017, and MSB11022 in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study.
Inflamm Bowel Dis
; 29(3): 376-383, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35579320
9.
Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn's disease: results from an Italian multicenter study.
Expert Opin Biol Ther
; 23(3): 293-304, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36843568
10.
Use of tofacitinib as first or second-line therapy is associated with better outcomes in patients with ulcerative colitis: data from a real-world study.
Expert Opin Pharmacother
; 24(14): 1649-1656, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37358928
11.
Adalimumab Biosimilar GP2017 versus Adalimumab Originator in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study.
Biomedicines
; 10(8)2022 Jul 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-35892698
12.
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy.
Expert Opin Biol Ther
; 22(2): 313-320, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34904510
13.
Replacement of Adalimumab Originator to Adalimumab Biosimilar for a Non-Medical Reason in Patients with Inflammatory Bowel Disease: A Real-life Comparison of Adalimumab Biosimilars Currently Available in Italy.
J Gastrointestin Liver Dis
; 31(4): 411-416, 2022 12 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36535057
14.
Colon metastasis from recurrent gallbladder cancer: a case report.
AME Case Rep
; 5: 21, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34312600
15.
Long-term, Real-life, Observational Study in Treating Outpatient Ulcerative Colitis with Golimumab.
J Gastrointestin Liver Dis
; 30(4): 456-461, 2021 12 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-34812437
16.
Long-term real-life efficacy and safety of infliximab and adalimumab in the treatment of inflammatory bowel diseases outpatients.
Eur J Gastroenterol Hepatol
; 33(5): 670-679, 2021 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33741797
17.
Infliximab biosimilar CT-P13 is effective and safe in treating inflammatory bowel diseases: a real-life multicenter, observational study in Italian primary inflammatory bowel disease centers.
Ann Gastroenterol
; 32(4): 392-399, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31263362
18.
Vedolizumab is effective and safe in real-life treatment of inflammatory bowel diseases outpatients: A multicenter, observational study in primary inflammatory bowel disease centers.
Eur J Intern Med
; 66: 85-91, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31208827
19.
Current practice for upper gastrointestinal endoscopy: a multicentre study in Lazio, Italy.
J Gastrointestin Liver Dis
; 32(2): 261-262, 2023 06 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37345596
20.
Effectiveness and safety of adalimumab to treat outpatient ulcerative colitis: A real-life multicenter, observational study in primary inflammatory bowel disease centers.
Medicine (Baltimore)
; 97(34): e11897, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-30142791